Multiplex analysis of circulating cytokines in the sera of patients with different clinical forms of visceral leishmaniasis
Open Access
- 18 April 2006
- journal article
- research article
- Published by Wiley in Cytometry Part A
- Vol. 69A (5) , 353-358
- https://doi.org/10.1002/cyto.a.20256
Abstract
Background: The clinical spectrum of visceral leishmaniasis (VL), a chronic intracellular parasitic disease, ranges from a subclinical, asymptomatic infection to severe clinical disease (kala-azar). In experimental leishmaniasis, mice that have a Th1 response to infection tend to have limited disease while a Th2 response is associated with disease progression. Humans with VL most often have mixed rather than polarized responses. However, most clinical studies have used methods that require a relatively large sample volume, thus limiting their scope. Measuring multiple cytokine levels in blood samples using a multiplexed microsphere assay (MMA) may be useful to further evaluate the Th1/Th2 paradigm in humans. Methods: Bangladeshi individuals (n = 120) living in an area endemic for VL were categorized into one of the five clinical categories. Sera from these individuals were measured for levels of IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IFN-γ, and TNF-α by multiplexed microsphere cytokine immunoassay. Results: Circulating IL-8, IL-10, and IL-12 differed significantly among the clinical groups. Persons with kala-azar demonstrated the highest median levels of IL-8 and IL-10 but lower median levels of IL-12. Conclusions: The MMA for cytokines is an extremely time-and sample-efficient method for characterizing circulating cytokine levels in visceral leishmaniasis patients. © 2006 International Society for Analytical CytologyKeywords
This publication has 23 references indexed in Scilit:
- Application of an Improved Method for the Recombinant K39 Enzyme-Linked Immunosorbent Assay To Detect Visceral Leishmaniasis Disease and Infection in BangladeshClinical and Vaccine Immunology, 2005
- Leishmaniasis: current situation and new perspectivesComparative Immunology, Microbiology and Infectious Diseases, 2004
- Visceral leishmaniasis in immunocompromised patients with and without AIDS: a comparison of clinical features and prognosisActa Tropica, 2004
- IL-12 as an adjuvant for cell-mediated immunitySeminars in Immunology, 1997
- The Regulation of Immunity to Leishmania MajorAnnual Review of Immunology, 1995
- Potential role for interleukin-10 in the immunosuppression associated with kala azar.Journal of Clinical Investigation, 1993
- In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma.Journal of Clinical Investigation, 1993
- Visceral Leishmaniasis (Kala-Azar) as an Opportunistic Infection in Patients Infected with the Human Immunodeficiency Virus in SpainClinical Infectious Diseases, 1989
- Profile of human T cell response to leishmanial antigens. Analysis by immunoblotting.Journal of Clinical Investigation, 1989
- Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.The Journal of Experimental Medicine, 1989